BCM
IMMX icon

Bridgeway Capital Management’s Immix Biopharma IMMX Stock Holding History

Bridgeway Capital Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$729K Buy
+80,000
New +$588K 0.01% 763

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Bridgeway Capital Management's IMMX Position: Q1 2026 in Review

Bridgeway Capital Management opened a new position in Immix Biopharma (IMMX) in Q1 2026: 80,000 shares worth $729K. The stake represents 0.01% of the portfolio and ranks #763 among its holdings.

77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Bridgeway Capital Management held 80,000 shares of Immix Biopharma worth $729K as of Q1 2026.
  • Immix Biopharma was a new Bridgeway Capital Management position in Q1 2026.
  • Immix Biopharma made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #763 holding.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.